Team:USTC CHINA/Project/Overview

From 2013.igem.org

(Difference between revisions)
Line 55: Line 55:
<div class="content" align="center">
<div class="content" align="center">
<div class="conbar1">
<div class="conbar1">
-
<div id="breadcrumb"><a href="">Home</a> &gt; <a href="">project</a> &gt; <a href="">overview</a></div></div>
+
<div id="breadcrumb"><a href="https://2013.igem.org/Team:USTC_CHINA">Home</a> &gt; <a href="https://2013.igem.org/Team:USTC_CHINA/Project">project</a> &gt; <a href="https://2013.igem.org/Team:USTC_CHINA/Overview">overview</a></div></div>
<div class="conbar2">
<div class="conbar2">
<div class="leftbar" align="left">
<div class="leftbar" align="left">

Revision as of 12:35, 25 September 2013

overview

T-VACCINE——A vaccine that can initiate immune response by penetrating the skin with the aid of transdermal peptide. From now on, injections are simply history! Based on the theory of user-friendly, a special group of engineering bacteria which produce T-VACCINE is used to create a brand-new "band-aid" that can serve as a guardian of our health .
We have found a kind of transdermal peptide TD-1——a magical molecule that not only enhances the permeability of the skin but also draw filamentous bacteriophages into the skin. By combining the gene fragments of antigen, immune adjuvant LTB and Luman-recruiting factor TNLFα with that of the transdermal peptide, our team got the permeable fusion protein. In order to obtain large amount of extracelluar protein, we chose bacillus subtilis WB800N as our expression engineering bacteria. At last, the universality of our experimental method is verified by the adoption of various antigen of existing vaccine, such as HBsAg, PA and AG85B.

Project Aimbitions

For in situ transdermal vaccine is real a giant project, we devide it into four lab parts. And we expect to achieve following goals.

Molecule part

Protein part

Mice part

Device

project

Retrieved from "http://2013.igem.org/Team:USTC_CHINA/Project/Overview"